Literature DB >> 33805696

Neuroprotective Effects of Thymoquinone by the Modulation of ER Stress and Apoptotic Pathway in In Vitro Model of Excitotoxicity.

Elisa Landucci1, Costanza Mazzantini1, Daniela Buonvicino1, Domenico E Pellegrini-Giampietro1, Maria Camilla Bergonzi2.   

Abstract

Experimental evidence indicates that the activation of ionotropic glutamate receptors plays an important role in neurological disorders' models such as epilepsy, cerebral ischemia and trauma. The glutamate receptor agonist kainic acid (KA) induces seizures and excitotoxic cell death in the CA3 region of the hippocampus. Thymoquinone (TQ) is the most important component of the essential oil obtained from black cumin (Nigella sativa L.) seeds. It has many pharmacological actions including antioxidant, anti-inflammatory, and anti-apoptotic effects. TQ was used in an in vitro experimental model of primary cultures where excitotoxicity was induced. Briefly, rat organotypic hippocampal slices were exposed to 5 µM KA for 24 h. Cell death in the CA3 subregions of slices was quantified by measuring propidium iodide fluorescence. The cross-talk between TQ, ER stress and apoptotic pathways was investigated by Western blot. In untreated slices TQ (10 µM) induced a significant increase on the PSD95 levels and it decreased the excitotoxic injury induced by KA. Additionally, TQ was able to ameliorate the KA-induced increase in unfolded proteins GRP78 and GRP94 expression. Finally, TQ was able to partially rescue the reduction of the KA-induced apoptotic pathway activation. Our results suggest that TQ modulates the processes leading to post-kainate neuronal death in the CA3 hippocampal area.

Entities:  

Keywords:  ER stress; apoptosis; excitotoxicity; neuroprotection; organotypic hippocampal slices; thymoquinone

Year:  2021        PMID: 33805696      PMCID: PMC7998420          DOI: 10.3390/molecules26061592

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  6 in total

Review 1.  Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases.

Authors:  Faheem Hyder Pottoo; Abdallah Mohammad Ibrahim; Ali Alammar; Rida Alsinan; Mahdi Aleid; Ali Alshehhi; Muruj Alshehri; Supriya Mishra; Noora Alhajri
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-27

2.  An aqueous extract of Khaya senegalensis (Desv.) A. Juss. (Meliaceae) prevents seizures and reduces anxiety in kainate-treated rats: modulation of GABA neurotransmission, oxidative stress, and neuronal loss in the hippocampus.

Authors:  Antoine Kavaye Kandeda; Stéphanie Lewale; Etienne Djeuzong; J Kouamouo; Théophile Dimo
Journal:  Heliyon       Date:  2022-05-26

3.  Hematological and biochemical investigations on the effect of curcumin and Thymoquinone in male mice exposed to Thioacetamide.

Authors:  Atef M Al-Attar
Journal:  Saudi J Biol Sci       Date:  2021-10-22       Impact factor: 4.219

4.  Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol.

Authors:  Elisa Landucci; Costanza Mazzantini; Daniele Lana; Maria Grazia Giovannini; Domenico E Pellegrini-Giampietro
Journal:  Toxics       Date:  2022-01-21

5.  An Anthranilate Derivative Inhibits Glutamate Release and Glutamate Excitotoxicity in Rats.

Authors:  Cheng-Wei Lu; Chen-Jung Lin; Pei-Wen Hsieh; Kuan-Ming Chiu; Ming-Yi Lee; Tzu-Yu Lin; Su-Jane Wang
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

6.  Preparation of Liposomal Formulations for Ocular Delivery of Thymoquinone: In Vitro Evaluation in HCEC-2 e HConEC Cells.

Authors:  Elisa Landucci; Francesca Bonomolo; Chiara De Stefani; Costanza Mazzantini; Domenico Edoardo Pellegrini-Giampietro; Anna Rita Bilia; Maria Camilla Bergonzi
Journal:  Pharmaceutics       Date:  2021-12-05       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.